Gut bacteria boost? new trial combines probiotic with cancer therapy for rectal tumors
Disease control
Recruiting now
This phase 2 trial is testing whether adding a probiotic called Probio-M9 to standard chemoradiation and an immunotherapy drug (tislelizumab) can improve outcomes for people with locally advanced rectal cancer. About 50 participants will be randomly assigned to receive either the…
Phase: PHASE2 • Sponsor: Seventh Medical Center of PLA General Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC